Source link : https://www.newshealth.biz/health-news/turns-out-that-biosimilars-do-impact-biologic-drug-costs/
Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a blockbuster, appears to have led to a dramatic drop in net spending for these products — even though biosimilars barely dented Humira prescription rates. Analysis of prescriptions and sales figures for 2023 — the first year in which […]
Author : News Health
Publish date : 2024-12-13 21:53:36
Copyright for syndicated content belongs to the linked Source.